首页 / 产品 / 抗体 / 一抗

Rabbit Polyclonal Src(Phospho-Tyr529) Antibody

  • 中文名: Src(Phospho-Tyr529)抗体
  • 别    名: C-SRC; SRC1;
货号: IPDX40148
Price: ¥1280
数量:
大包装询价

验证与应用

应用及物种
WB 咨询技术 Human,Mouse,Rat
IF 咨询技术 Human,Mouse,Rat
IHC 1/50-1/100 Human,Mouse,Rat
ICC 1/100-1/200 Human,Mouse,Rat
FCM 咨询技术 Human,Mouse,Rat
Elisa 咨询技术 Human,Mouse,Rat

产品详情

参考文献

以下是关于 Src (Phospho-Tyr529) 抗体的参考文献示例(注:文献信息为模拟示例,实际引用时请核实真实性和准确性):

---

1. **"Regulation of Src kinase activity by C-terminal phosphorylation at Tyr529"**

*Author: Chong YP, et al. (2004)*

**摘要**:研究通过 Western blot 和免疫沉淀实验,利用抗 Src (Phospho-Tyr529) 抗体证实了 Tyr529 磷酸化对 Src 激酶活性的抑制作用,并揭示了其与 Csk 激酶的调控关系。

2. **"Dynamic interactions between Src and PTPα in cell adhesion signaling"**

*Author: Zheng XM, et al. (2002)*

**摘要**:通过免疫荧光和磷酸化特异性抗体(包括抗 Src pY529),阐明了 Tyr529 磷酸化在 Src 与蛋白酪氨酸磷酸酶 PTPα 结合中的关键作用,及其对细胞黏附通路的调控。

3. **"Structural basis of Src autoinhibition by phosphotyrosine 529"**

*Author: Sicheri F, et al. (1997)*

**摘要**:结合 X 射线晶体学与抗 pY529 抗体的功能实验,揭示了 Tyr529 磷酸化诱导 Src 构象变化并封闭激酶结构域的分子机制。

4. **"Targeting Src phosphorylation in cancer therapy"**

*Author: Bjorge JD, et al. (2008)*

**摘要**:综述了 Src 磷酸化位点(包括 Tyr529)在肿瘤中的异常调控,并讨论了基于 pY529 抗体检测的临床前研究在药物开发中的应用。

---

**注意**:以上文献名称、作者及摘要内容为示例性质,实际引用需通过 PubMed 或 Web of Science 等数据库检索真实文献。建议使用关键词 **"Src Y529 phosphorylation"** 或 **"Phospho-Src (Tyr529) antibody"** 进一步筛选。

背景信息

The Src (Phospho-Tyr529) antibody is designed to detect the phosphorylated form of tyrosine residue 529 (Tyr529) in the Src protein, a non-receptor tyrosine kinase involved in regulating cell proliferation, differentiation, adhesion, and survival. Src activity is tightly controlled by phosphorylation at specific residues. Phosphorylation at Tyr529 (corresponding to Tyr530 in human Src due to species-specific numbering) by C-terminal Src kinase (CSK) induces a closed, inactive conformation by promoting intramolecular interactions between the SH2 domain and the phosphorylated tail. This inhibits Src kinase activity and downstream signaling. Conversely, dephosphorylation of Tyr529 by protein tyrosine phosphatases activates Src, enabling its participation in oncogenic pathways when dysregulated. The Src (Phospho-Tyr529) antibody is widely used in cancer research, as hyperactivation of Src through reduced phosphorylation at this site is linked to tumor progression, metastasis, and drug resistance. It serves as a critical tool for studying Src regulatory mechanisms, signaling crosstalk, and therapeutic targeting in diseases like breast, colon, and pancreatic cancers. Specificity for the phosphorylated Tyr529 ensures accurate detection of Src inactivation status in applications such as Western blotting, immunohistochemistry, and flow cytometry.

客户数据及评论

折叠内容

大包装询价

×